Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial

JAMA Neurology

Volumn 75, Issue 1, 2018, Pages 35-43

  Zamboni, Paolo ^a   Tesio, Luigi ^b,c   Galimberti, Stefania ^d   Massacesi, Luca ^e   Salvi, Fabrizio ^f   D'Alessandro, Roberto ^f   Cenni, Patrizia ^g   Galeotti, Roberto ^h   Papini, Donato ⁱ   D'Amico, Roberto ^j   Simi, Silvana ^k   Valsecchi, Maria Grazia ^d   Filippini, Graziella ^l   Ceruti, Stefano ^a   Conforti, Paolo ^a   Malagoni, Anna Maria ^a   Menegatti, Erica ^a   Tessari, Mirko ^a   Pancaldi, Francesca ^a   Vanini, Maria Elena ^a   Barbarossa, Elena ^f   Bartolomei, Ilaria ^f   Pellegrino, Lisa ^f   Piscaglia, Maria Grazia ^m   Rasi, Fabrizio ^m   Babini, Maria ^m   Drea, Antonella ^m   Guerrini, Eugenia ^m   Lotti, Enrico Maria ^m   Morelli, Agnese ^m   Peroni, Milena ^m   Zalambani, Valentina ^m   Zecchini, Sauro ^m   Patti, Francesco ⁿ   Chisari, Clara ⁿ   Chiaramonte, Ignazio ⁿ   Cimino, Vincenzo ⁿ   Giaquinta, Alessia ⁿ   Di Pino, Luigi ⁿ   Failla, Gianni ⁿ   Veroux, Pierfrancesco ⁿ   Cantello, Roberto ^o   Leone, Maurizio ^o   Coppo, Lorenzo ^o   Guzzardi, Giuseppe ^o   Raymkulova, Olga ^o   Ruggerone, Simona ^o   Stecco, Alessandro ^o   Vecchio, Domizia ^o   Confalonieri, Paolo Agostino ^l   Campanella, Angela ^l   Caldiera, Valentina ^l   Ciceri, Elisa ^l   Erbetta, Alessandra ^l   Faragò, Giuseppe ^l   Parma, Leila ^l   Reggiori, Barbara ^l   Clerici, Valentina Torri ^l   Danni, Maura ^p   Arborino, Salvatore ^p   De Berardinis, Fabiana ^p   Di Biagio, Laura ^p   Orni, Chiara ^p   Renzi, Rosita ^p   Rosettani, Pamela ^p   Zagaglia, Sara ^p   Luccioni, Giuseppe ^q   Oncini, Luigi ^q   Quatrini, Cristina ^q   more..

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f BELLARIA HOSPITAL   (Italy)

^g Ravenna Hospital   (Italy)

^h UNIVERSITY OF FERRARA   (Italy)

ⁱ Regional Agency for Health and Social Care Regione Emilia Romagna   (Italy)

^j UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^k INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^l DEPARTMENT OF NEUROSURGERY   (Italy)

^m SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

ⁿ UNIVERSITY OF CATANIA   (Italy)

^o MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^p OSPEDALI RIUNITI   (Italy)

^q Civitanova Marche Hospital   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; AGE; ARTICLE; BRAIN DAMAGE; CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY; CLINICAL EFFECTIVENESS; COLOR DOPPLER FLOWMETRY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENDER; HUMAN; INTENTION TO TREAT ANALYSIS; ITALY; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALLEL DESIGN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SHAM PROCEDURE; TREATMENT OUTCOME; VISUAL ACUITY; WALKING; ADOLESCENT; AGED; ANGIOPLASTY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; IMAGE PROCESSING; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANGIOPLASTY; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ITALY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; YOUNG ADULT;

EID: 85040236861     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2017.3825     Document Type: Article

References (29)

1. Lee BB, Baumgartner I, Berlien P, et al; International Union of Phlebology. Diagnosis and treatment of venous malformations: consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol. 2015;34(2):97-149.
2. Zivadinov R, Bastianello S, Dake MD, et al; International Society for Neurovascular Disease. Recommendations for multimodal noninvasive and invasive screening for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency: a position statement of the International Society for Neurovascular Disease. J Vasc Interv Radiol. 2014; 25(11):1785-1794.e17.
3. Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009;50(6): 1348-1358.e1, 3.
4. Chafe R, Born KB, Slutsky AS, Laupacis A. The rise of people power. Nature. 2011;472(7344): 410-411.
5. Zamboni P, Galeotti R, Weinstock-Guttman B, Kennedy C, Salvi F, Zivadinov R. Venous angioplasty in patients with multiple sclerosis: results of a pilot study. Eur J Vasc Endovasc Surg. 2012;43(1):116-122.
6. Ministero della Salute Consiglio Superiore di Sanita. Trasmissione parere "Insufficienza venosa cerebro-spinale cronica (CCSVI) e sclerosi multipla (SM)." Roma, Italy: Sessione XLVIII; 2011.
7. National Institute for Health and Care Excellence. Percutaneous venoplasty for chronic cerebrospinal venous insufficiency for multiple sclerosis. https://www.nice.org.uk/guidance/ipg420. Accessed March 16, 2017.
8. Zamboni P, Bertolotto A, Boldrini P, et al; Chair of the Steering Committee. Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis: Brave Dreams study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial. Trials. 2012;13:183.
9. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol. 2005;58(6):840-846.
10. Lublin FD, Reingold SC; National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996; 46(4):907-911.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33(11):1444-1452.
12. Nicolaides AN, Morovic S, Menegatti E, Viselner G, Zamboni P. Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound: recommendations for a protocol. Funct Neurol. 2011;26(4):229-248.
13. Ebers GC, Heigenhauser L, Daumer M, Lederer C, Noseworthy JH. Disability as an outcome in MS clinical trials. Neurology. 2008;71(9):624-631.
14. Cohen JA, Reingold SC, Polman CH, Wolinsky JS; International Advisory Committee on Clinical Trials in Multiple Sclerosis. Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol. 2012;11 (5):467-476.
15. Tesio L. Outcome measurement in behavioural sciences: a view on how to shift attention from means to individuals and why. Int J Rehabil Res. 2012;35(1):1-12.
16. European Agency for the Evaluation of Medicinal Products. Points to consider on multiplicity issues in clinical trials. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003640.pdf. Accessed December 21, 2016.
17. Hommel G. A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika. 1988;75:383-386.
18. Gaitan MI, Shea CD, Evangelou IE, et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol. 2011; 70(1):22-29.
19. Iliff JJ, Lee H, Yu M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013;123(3):1299-1309.
20. Zivadinov R, Magnano C, Galeotti R, et al. Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case-control study. J Vasc Interv Radiol. 2013;24 (6):829-838.
21. Zamboni P, Menegatti E, Cittanti C, et al. Fixing the jugular flow reduces ventricle volume and improves brain perfusion. J Vasc Surg Venous Lymphat Disord. 2016;4(4):434-445.
22. Bateman GA, Lechner-Scott J, Lea RA. A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS? Fluids Barriers CNS. 2016;13(1):18.
23. Magnano C, Schirda C, Weinstock-Guttman B, et al. Cine cerebrospinal fluid imaging in multiple sclerosis. J Magn Reson Imaging. 2012;36(4): 825-834.
24. Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain. 2004;127(pt 1):111-119.
25. Holland CM, Charil A, Csapo I, et al. The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1249 patients with multiple sclerosis. J Neuroimaging. 2012;22(2):129-136.
26. Siddiqui AH, Zivadinov R, Benedict RH, et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology. 2014;83(5):441-449.
27. Salvi F, Bartolomei I, Buccellato E, Galeotti R, Zamboni P. Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients. Funct Neurol. 2012;27 (1):55-59.
28. Paul F, Wattjes MP. Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain. Lancet. 2014;383(9912):106-108.
29. Chalmers I. Unbiased, relevant, and reliable assessments in health care: important progress during the past century, but plenty of scope for doing better. BMJ. 1998;317(7167):1167-1168.